ORIGINAL RESEARCH
Accepted on 09 Jun 2025
BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective study
doi 10.3389/fimmu.2025.1618110